← Eichor
Study identifier: NCT06024837 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study

Condition: Colo-rectal Cancer  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Spectral CT is a rapidly expanding imaging modality that allows a reduction in iodine dose and irradiation compared to conventional scanning. It uses the difference in attenuation of the material according to the two different energy levels of the incident x-ray beams. The dual-energy scanner has a wide range of clinical applications, particularly in abdominal imaging.

This description comes directly from the study's public registry record.

Talk to the study team

Rémi GRANGE, MD  ·  (0)477828963  ·  remi.grange@chu-st-etienne.fr

Sylvain GRANGE, MD  ·  (0)477829066  ·  sylvain.grange@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Saint-EtienneSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06024837